DUBLIN--(BUSINESS WIRE)--The "Influenza Diagnostics Market by Test type (Molecular (RT-PCR,LAMP, NASBA), Traditional (Viral Culture, Direct Fluorescent Antibody, Rapid Influenza Detection Tests, Serological Assays)), End user (Hospital, Clinical Laboratories) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global influenza diagnostics market was worth USD 695.3 million in 2020.
The major factors driving the growth of this market include increasing prevalence of influenza, growth in research funding for influenza diagnostics, and the rising demand for faster diagnosis are expected to drive the overall growth of the influenza diagnostic market.
The traditional diagnostic segment commanded the largest share of the market in 2019.
On the basis of test type, the market is broadly segmented into traditional diagnostic tests and molecular diagnostic tests. The RIDT segment accounted for the largest share of the influenza diagnostics market for traditional diagnostic tests of the influenza diagnostic market in 2019. The large share of this segment can be attributed to increased adoption of cost-effective and faster RIDT as a first line of diagnosis and screening process have been increased among the end-users. This is a major factor responsible for the largest share of the RIDT market.
The hospital's segment commanded the largest share of the influenza diagnostic market in 2019.
Based on end-user, the influenza diagnostic market has been categorized into hospitals, clinical laboratories, and other end-user. The hospitals segment commanded the largest share of the market in 2019. The large number of minimally invasive surgical procedures performed in hospitals due to the presence of highly skilled healthcare professionals is a major factor driving market growth.
The Asia Pacific region to register the highest growth in the global MIS instruments market during the forecast period.
The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Influenza disease diagnostics is commonly carried out in hospitals, as it is complex in nature and requires technologically advanced product, this is the major factor driving the growth of this segment.
- Increasing Prevalence of Influenza
- Growth in Influenza Research
- Rising Demand for Rapid Disease Diagnosis
- Variability in Test Sensitivity and Specificity
- Stringent Regulatory Framework
- Rising Healthcare Costs
- Advancements in Genomic and Proteomic Technologies
- Significant Growth Prospects in Developing Countries
- Lack of Skilled Professionals
- F. Hoffmann-La Roche Ag
- Quidel Corporation
- Thermo Fisher Scientific, Inc.
- Abbott Laboratories, Inc.
- Hologic, Inc.
- Becton, Dickinson and Company
- Danaher Corporation
- Diasorin Sa
- Meridian Bioscience
- Luminex Corporation
- Biomrieux Sa
- Genmark Diagnostics, Inc.
- Siemens Healthineers
- Tecan Trading
- Sekisui Diagnostics
- Sa Scientific, Ltd.
- Altona Diagnostics Gmbh
- Coris Bioconcept Sprl
- Elitech Group
- Mast Group Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/thved8